Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
AssigneesRegenerx Biopharmaceuticals, Inc., Universitaet Erlangen-Nuernberg
InventorsEwald Hannappel, Thomas Huff, Allan Goldstein
Life of this patent
Estimating the term…
Abstract
A method of treatment for promoting regeneration or repair a damaged cardiovascular tissue, or for preventing damage to cardiovascular tissue, includes administering to the tissue a damage-treating or -preventing fragment of thymosin beta 4 (Tβ4), such as AcSDKP, or a stimulating agent that forms such a fragment of (Tβ4).
Claims4
A method of treatment for promoting regeneration or repair of damaged cardiovascular tissue, or for preventing damage to cardiovascular tissue, comprising administering to the tissue a damage-treating or -preventing fragment of thymosin beta 4 (Tβ4) or a stimulating agent that forms such a fragment of Tβ4.
Dependencies are inferred from the claim text.